(Q34358631)

English

Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease (English)

1 reference

Europe PubMed Central

1 August 2017

hypercholesterolemia

0 references

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Barrow SE

1

1 reference

Europe PubMed Central

1 August 2017

Stratton PD

2

1 reference

Europe PubMed Central

1 August 2017

Benjamin N

3

1 reference

Europe PubMed Central

1 August 2017

Brassfield T

4

1 reference

Europe PubMed Central

1 August 2017

Ritter JM

5

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 July 1991

1 reference

Europe PubMed Central

1 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

1 August 2017

32

1 reference

Europe PubMed Central

1 August 2017

127-129

1 reference

Europe PubMed Central

1 August 2017

1

1 reference

Europe PubMed Central

1 August 2017

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368505

6 July 2018

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368505

6 July 2018

Paired analysis of urinary thromboxane B2 metabolites in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368505

6 July 2018

Platelet activation by plasma lipoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368505

6 July 2018

Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368505

6 July 2018

Measurement of renal and non-renal eicosanoid synthesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368505

6 July 2018

Effects of synvinolin on platelet aggregation and thromboxane B2 synthesis in type IIa hypercholesterolemic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368505

6 July 2018

Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368505

6 July 2018

Cholestyramine treatment of type IIa hypercholesterolaemia normalizes platelet reactivity against prostacyclin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB05625.X

21 January 2018

Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1909541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet function and lipoprotein levels after plasma-exchange in patients with familial hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1909541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1909541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1909541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.1991.TB05625.X

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34358631&oldid=1630045620"